跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 52,872 条关于
“Bcl2-associated athanogene 3”
全部
52,872
临床试验
27,331
药物
5,022
机构
1,458
资讯
19,061
去年
Affinia Therapeutics Partners with DCM Foundation to Advance BAG3 Dilated Cardiomyopathy Awareness and Genetic Testing
2年前
BCL2 Protein Identified as Potential Drug Target in Aggressive Prostate Cancer
2年前
Managing Toxicities in CLL Treatment: Expert Insights on BCL2 and BTK Inhibitor Selection
去年
Novel BTK-BCL2 Inhibitor Combination Shows Promise Against Drug-Resistant DLBCL with BCL10 Mutations
2年前
InnoCare Advances Dual Regulatory Milestones with Tafasitamab BLA Acceptance and BCL2 Inhibitor ICP-248 Clinical Trial Approval in China
去年
InnoCare's BCL2 Inhibitor ICP-248 Combination Therapy Advances to Phase III Trial for First-line CLL/SLL Treatment in China
10个月前
Adaptam Therapeutics Secures €3 Million to Develop Novel Cancer Immunotherapies Targeting Tumor-Associated Myeloid Cells
去年
NAPOLI 3 Post-Hoc Analysis Identifies Characteristics Associated with Long-Term Survival in Metastatic Pancreatic Cancer
去年
Amgen's Tavneos Enters Phase 3 Trial for Pediatric ANCA-Associated Vasculitis
去年
Gyre Therapeutics' F351 Completes Phase 3 Trial for CHB-Associated Liver Fibrosis
第 1 页，共 1907 页
上一页
下一页
